Poietis

Poietis

Private
PessacHealthcare & Life Scienceshttps://www.poietis.com/

Last Round

Series A

Mar 27, 2018

Total Funding Raised

$11.98M

Company Overview

Poietis is a biotechnology company that develops and produces human tissues using 4D laser-assisted bioprinting for pharmaceutical, cosmetic, and regenerative medicine applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, 3D Printing, Biotech Equipment, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts, Hardware + Subscription

AI Layer

Application

Keywords

4D bioprintinglaser-assisted bioprintingtissue engineeringhuman tissue modelsbioprinting platformbiofabricationalternatives to animal testingregenerative medicinebioprinted skindrug discoveryin vitro models3D cell culturecosmetic testingmultimodal bioprinterAI-guided bioprinting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Poietis Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Poietis Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMar 27, 2018
SeedDec 17, 2015

Poietis Investors

Notable investors and investment history

InvestorRounds
Concours Mondial d'InnovationSeries A
Nouvelle-Aquitaine Co-investissementCrowdfunding, Series A
Aquitaine Science TransfertSeed
Michelin DevelopmentSeed
WiSeedCrowdfunding, Series A, Seed
French Tech BridgeCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 27, 2018

    Raised $6.2M from government and other investors.

  • Dec 17, 2015

    $2.75M raised from Aquitaine Science Transfert and others.

Poietis Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Poietis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Poietis's valuation, stock price, and market status.

Firmographic Details

HeadquartersPessac
Employee Range15
Year Founded2014
Last FundingMar 27, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.